Steve H Kanzer's Net Worth
$4.38 Million
Who is Steve H Kanzer?
Steve H Kanzer has an estimated net worth of $4.38 Million. This is based on reported shares across multiple companies, which include PIPEX PHARMACEUTICALS, INC., and DOR BIOPHARMA INC.
SEC CIK
Steve H Kanzer's CIK is 0001076653
Past Insider Trading and Trends
2007 was Steve H Kanzer's most active year for acquiring shares with 97 total transactions. Steve H Kanzer's most active month to acquire stocks was the month of June. 2006 was Steve H Kanzer's most active year for disposing of shares, totalling 1 transactions. Steve H Kanzer's most active month to dispose stocks was the month of December. 2007 saw Steve H Kanzer paying a total of $2,186,682.62 for 1,004,061 shares, this is the most they've acquired in one year. In 2006 Steve H Kanzer cashed out on 250,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PIPEX PHARMACEUTICALS, INC. (TOVX) Snapshot price: $4.37
ChairmanSteve H Kanzer owns 375,246 units of Common Stock which is worth $1,639,825.02. In the year 2006 Steve H Kanzer acquired a total of 737,738 shares in PIPEX PHARMACEUTICALS, INC. at a cost of $2,131,110.42.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -69.50% | -5.00M |
$1.43 | -$7,154,325.75 | 2.2M |
Apr 30
| |||
Form 4
| -3.71% | -263.11K |
$2.90 | -$763,052.52 | 6.82M |
Apr 28 - Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
| +2,194.15% | 7.14M |
$0.89 | $44,427.82 | 7.46M |
Oct 31 - Apr 11
| |||
Form 4
| +2,283.57% | 7.1M |
$7.22 | $103,281.00 | 7.41M |
Oct 31 - Jul 25
| |||
Form 4
| +2,341.80% | 7.09M |
$7.13 | $57,025.00 | 7.4M |
Oct 31 - Jul 24
| |||
Form 4
| +2,604.28% | 7.12M |
$6.75 | $200,351.00 | 7.39M |
Oct 31 - Jul 23
| |||
Form 4
| +2,864.65% | 7.11M |
$5.25 | $131,171.00 | 7.36M |
Oct 31 - Jul 17
| |||
Form 4/A
| +4,285.53% | 7.17M |
$4.84 | $391,962.30 | 7.33M |
Oct 31 - Jul 16
| |||
Form 4
| +4,285.53% | 7.17M |
$2.76 | $5,139,836.23 | 7.33M |
Nov 2 - Jul 16
| |||
Form 4
| +6.28% | 26.5K |
$5.30 | $140,350.10 | 448.74K |
Jan 27 - May 11
| |||
Form 4
| +116.27% | 227K |
$1.96 | $445,580.00 | 422.24K |
Jan 27 - Apr 17
| |||
Form 4
| +105.00% | 100K |
$1.25 | $125,000.00 | 195.24K |
Feb 27
| |||
Form 4
|
∞
| 95.24K |
$1.05 | $99,999.90 | 95.24K |
Feb 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DOR BIOPHARMA INC (SNGX) Snapshot price: $3.92
InvestorSteve H Kanzer owns 1,282,203 units of Common Stock which is worth $5,026,235.76.acquired a total of 467,766 shares in DOR BIOPHARMA INC at a cost of $153,750.02.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.90% | 212.77K |
$0.47 | $100,000.02 | 1.28M |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
| +30.51% | 250K |
$0.20 | $50,000.00 | 1.07M |
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
| +0.61% | 5K |
$0.75 | $3,750.00 | 819.44K |
Nov 25
| |||
Form 4
|
∞
| 125.63K |
$0.80 | $99,999.89 | 125.63K |
Sep 15
| |||
| No matching records found | |||||||||